Nrx pharmaceuticals announces leadership transition

Radnor, pa., march 8, 2022 /prnewswire/ -- nrx pharmaceuticals (nasdaq: nrxp) ("nrx" or the "company"), a clinical-stage, biopharmaceutical company, today announced that jonathan javitt, md, mph, has retired as chief executive officer effective immediately.
NRXP Ratings Summary
NRXP Quant Ranking